标题
Type 3 secretion system as an anti-Pseudomonal target
作者
关键词
T3SS, Anti-virulence, Pseudomonas aeruginosa, T3SS inhibitors, PcrV vaccines
出版物
MICROBIAL PATHOGENESIS
Volume 155, Issue -, Pages 104907
出版商
Elsevier BV
发表日期
2021-04-28
DOI
10.1016/j.micpath.2021.104907
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A pipeline to evaluate inhibitors of the Pseudomonas aeruginosa Exotoxin U
- (2021) Daniel Morgan Foulkes et al. BIOCHEMICAL JOURNAL
- Iron Chelation in Local Infection
- (2021) Cassidy Scott et al. MOLECULES
- Identification of Small Molecules Blocking the Pseudomonas aeruginosa Type III Secretion System Protein PcrV
- (2021) Charlotta Sundin et al. Biomolecules
- Type 3 secretion system of Pseudomonas aeruginosa
- (2021) Gertrudis Horna et al. MICROBIOLOGICAL RESEARCH
- Type three secretion system in Salmonella Typhimurium: the key to infection
- (2020) Anamaria M. P. dos Santos et al. Genes & Genomics
- Exploring resveratrol dimers as virulence blocking agents – Attenuation of type III secretion in Yersinia pseudotuberculosis and Pseudomonas aeruginosa
- (2020) Charlotta Sundin et al. Scientific Reports
- Escherichia coli ST131 clones harbouring AggR and AAF/V fimbriae causing bacteremia in Mozambican children: Emergence of new variant of fimH27 subclone
- (2020) Inácio Mandomando et al. PLoS Neglected Tropical Diseases
- Antimicrobial resistance and virulence of Pseudomonas spp. among healthy animals: concern about exolysin ExlA detection
- (2020) Lidia Ruiz-Roldán et al. Scientific Reports
- Exoenzyme Y Contributes to End-Organ Dysfunction Caused by Pseudomonas aeruginosa Pneumonia in Critically Ill Patients: An Exploratory Study
- (2020) Brant M. Wagener et al. Toxins
- Cell Death Signaling Pathway Induced by Cholix Toxin, a Cytotoxin and eEF2 ADP-Ribosyltransferase Produced by Vibrio cholerae
- (2020) Kohei Ogura et al. Toxins
- Synthesis and biological evaluation of 1,3,4-thiadiazole derivatives as type III secretion system inhibitors against Xanthomonas oryzae
- (2019) Hui Tao et al. PESTICIDE BIOCHEMISTRY AND PHYSIOLOGY
- High frequency of the exoU+/exoS+ genotype associated with multidrug-resistant “high-risk clones” of Pseudomonas aeruginosa clinical isolates from Peruvian hospitals
- (2019) Gertrudis Horna et al. Scientific Reports
- Tanshinones: First-in-Class Inhibitors of the Biogenesis of the Type 3 Secretion System Needle of Pseudomonas aeruginosa for Antibiotic Therapy
- (2019) Chao Feng et al. ACS Central Science
- Modulating pathogenesis with Mobile-CRISPRi
- (2019) Jiuxin Qu et al. JOURNAL OF BACTERIOLOGY
- Novel S-Thiazol-2-yl-furan-2-carbothioate Derivatives as Potential T3SS Inhibitors Against Xanthomonas oryzae on Rice
- (2019) Shan Jiang et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- KB001-A, a novel anti-inflammatory, found to be safe and well-tolerated in cystic fibrosis patients infected with Pseudomonas aeruginosa
- (2018) R. Jain et al. Journal of Cystic Fibrosis
- Phase 1 study of MEDI3902, an investigational anti–Pseudomonas aeruginosa PcrV and Psl bispecific human monoclonal antibody, in healthy adults
- (2018) S.O. Ali et al. CLINICAL MICROBIOLOGY AND INFECTION
- Small Molecule Inhibitor of Type Three Secretion System Belonging to a Class 2,4-disubstituted-4H-[1,3,4]-thiadiazine-5-ones Improves Survival and Decreases Bacterial Loads in an Airway Pseudomonas aeruginosa Infection in Mice
- (2018) Anna B. Sheremet et al. Biomed Research International
- Specific type IV pili groups in clinical isolates of Pseudomonas aeruginosa
- (2018) Gertrudis Horna et al. INTERNATIONAL MICROBIOLOGY
- Host and Pathogen Biomarkers for Severe Pseudomonas aeruginosa Infections
- (2017) Carlos Juan et al. JOURNAL OF INFECTIOUS DISEASES
- Protective Efficacy of the Trivalent Pseudomonas aeruginosa Vaccine Candidate PcrV-OprI-Hcp1 in Murine Pneumonia and Burn Models
- (2017) Feng Yang et al. Scientific Reports
- Pathogenicity Island O-122 in enteropathogenic Escherichia coli strains is associated with diarrhea severity in children from Lima Peru
- (2016) Erik H. Mercado et al. INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
- Targeting the Type Three Secretion System in Pseudomonas aeruginosa
- (2016) Ahalieyah Anantharajah et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Inhibition of Pseudomonas aeruginosa ExsA DNA-Binding Activity byN-Hydroxybenzimidazoles
- (2015) Anne E. Marsden et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Enhanced annotations and features for comparing thousands ofPseudomonasgenomes in the Pseudomonas genome database
- (2015) Geoffrey L. Winsor et al. NUCLEIC ACIDS RESEARCH
- Mutations in the Pseudomonas aeruginosa Needle Protein GenepscFConfer Resistance to Phenoxyacetamide Inhibitors of the Type III Secretion System
- (2014) Nicholas O. Bowlin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparative Systems Biology Analysis To Study the Mode of Action of the Isothiocyanate Compound Iberin on Pseudomonas aeruginosa
- (2014) Sean Yang-Yi Tan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Correction: Identification of Small Molecule Inhibitors of Pseudomonas aeruginosa Exoenzyme S Using a Yeast Phenotypic Screen
- (2014) Anthony Arnoldo et al. PLoS Genetics
- Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system
- (2013) David Bikard et al. NUCLEIC ACIDS RESEARCH
- Anti-PcrV antibody in cystic fibrosis: A novel approach targetingPseudomonas aeruginosaairway infection
- (2013) Carlos E. Milla et al. PEDIATRIC PULMONOLOGY
- The Resveratrol Tetramer (-)-Hopeaphenol Inhibits Type III Secretion in the Gram-Negative Pathogens Yersinia pseudotuberculosis and Pseudomonas aeruginosa
- (2013) Caroline E. Zetterström et al. PLoS One
- Th17-stimulating Protein Vaccines Confer Protection againstPseudomonas aeruginosaPneumonia
- (2012) Weihui Wu et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Food as a Source for Quorum Sensing Inhibitors: Iberin from Horseradish Revealed as a Quorum Sensing Inhibitor of Pseudomonas aeruginosa
- (2012) Tim Holm Jakobsen et al. APPLIED AND ENVIRONMENTAL MICROBIOLOGY
- Safety and pharmacokinetics of an anti-PcrV PEGylated monoclonal antibody fragment in mechanically ventilated patients colonized with Pseudomonas aeruginosa
- (2012) Bruno François et al. CRITICAL CARE MEDICINE
- The Non-Flagellar Type III Secretion System Evolved from the Bacterial Flagellum and Diversified into Host-Cell Adapted Systems
- (2012) Sophie S. Abby et al. PLoS Genetics
- Derivatives of Plant Phenolic Compound Affect the Type III Secretion System of Pseudomonas aeruginosa via a GacS-GacA Two-Component Signal Transduction System
- (2011) Akihiro Yamazaki et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Modified Needle-Tip PcrV Proteins Reveal Distinct Phenotypes Relevant to the Control of Type III Secretion and Intoxication by Pseudomonas aeruginosa
- (2011) Hiromi Sato et al. PLoS One
- Role of Pseudomonas aeruginosa type III effectors in disease
- (2009) Joanne Engel et al. CURRENT OPINION IN MICROBIOLOGY
- The type III secretion system of Pseudomonas aeruginosa: infection by injection
- (2009) Alan R. Hauser NATURE REVIEWS MICROBIOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started